Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 1-2 Study of PLM60 in Patients With Peripheral T-Cell Lymphoma

NCT03553914 is registered in ClinicalTrials.gov with Conjupro Biotherapeutics, Inc. as lead sponsor.

NCT NCT03553914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03553914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 1-2 Study of PLM60 in Patients With Peripheral T-Cell Lymphoma
Lead sponsor
Conjupro Biotherapeutics, Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 31, 2021
Completion date
January 31, 2025
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t cell lymphoma